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Georgina Krebs, DClinPsy, Katie Lang, MPhil, Sarah Byford, PhD, Isobel Heyman, PhDObjective: Many adolescents with obsessive-compulsive disorder (OCD) do not have access
to evidence-based treatment. A randomized controlled non-inferiority trial was conducted in
a specialist OCD clinic to evaluate the effectiveness of telephone cognitive-behavioral therapy
(TCBT) for adolescents with OCD compared to standard clinic-based, face-to-face
CBT. Method: Seventy-two adolescents, aged 11 through 18 years with primary OCD, and
their parents were randomized to receive specialist TCBT or CBT. The intervention provided
differed only in the method of treatment delivery. All participants received up to 14 sessions
of CBT, incorporating exposure with response prevention (E/RP), provided by experienced
therapists. The primary outcome measure was the Children’s Yale–Brown Obsessive-
Compulsive Scale (CY-BOCS). Blind assessor ratings were obtained at midtreatment, post-
treatment, 3-month, 6-month, and 12-month follow-up. Results: Intent-to-treat analyses
indicated that TCBT was not inferior to face-to-face CBT at posttreatment, 3-month, and
6-month follow-up. At 12-month follow-up, there were no signiﬁcant between-group differ-
ences on the CY-BOCS, but the conﬁdence intervals exceeded the non-inferiority threshold.
All secondary measures conﬁrmed non-inferiority at all assessment points. Improvements
made during treatment were maintained through to 12-month follow-up. Participants in each
condition reported high levels of satisfaction with the intervention received. Conclusion:
TCBT is an effective treatment and is not inferior to standard clinic-based CBT, at least in
the midterm. This approach provides a means of making a specialized treatment more
accessible to many adolescents with OCD. Clinical trial registration information–Evaluation
of telephone-administered cognitive-behaviour therapy (CBT) for young people with
obsessive-compulsive disorder (OCD); http://www.controlled-trials.com; ISRCTN27070832.
J. Am. Acad. Child Adolesc. Psychiatry, 2014;53(12):1298–1307. Key Words: OCD, psy-
chotherapy, CBT, telehealthbsessive-compulsive disorder (OCD) in
children and adolescents is a chronicO disorder that can cause functional im-
pairment across multiple life domains.1,2 Esti-
mates suggest that approximately 1 in 100 young
persons suffers from OCD.3 Cognitive-behavioral
therapy (CBT) incorporating exposure and re-
sponse prevention (E/RP) is the recommended
psychological treatment for pediatric OCD.4,5Supplemental material cited in this article is available online.
JOURN
www.jaacap.orgHowever, CBT is not readily available to all
who need it because of a variety of factors, and
geographical and ﬁnancial barriers prevent many
from receiving treatment.
Telehealth is an area of mental health practice
that offers signiﬁcant potential for improving
access to specialized treatments.6 Telehealth in-
volves the use of telecommunication tools (e.g.,
telephone, Internet, video-conferencing) as a
means for health professionals to provide treat-
ment remotely. Telehealth applications of psy-
chological treatments have grown in popularity,
as they have shown effectiveness7 but also offer
additional beneﬁts such as reduced time andAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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TELEPHONE CBT FOR ADOLESCENT OCDcost.8 A number of recent controlled trials dem-
onstrate efﬁcacy of telehealth interventions for
adult mental health disorders; examples include
social phobia,9 depression,10 and OCD.11,12 In-
creasingly, there is evidence of successful piloting
telehealth interventions for childhood disorders,
including a pilot study of webcam-delivered
CBT for adolescent OCD,13 tic disorders,14 and
depression.15 Telehealth treatment typically en-
tails the same components as conventional face-
to-face CBT but is simply delivered remotely,
via a device.
Within the variety of telehealth methods
available, telephone CBT (TCBT) has some im-
portant advantages for service providers and
users, including relative ease of administration.16
There is no need for hi-technology equipment, as
most clinics have access to telephones and tele-
phone ports, and many service users have a
telephone or access to one. For these reasons, plus
evidence suggesting that relatively few adoles-
cents with OCD are able to access CBT17 despite it
being the recommended treatment,18 TCBT was
piloted for success and feasibility with adoles-
cents with OCD in a London-based specialist
clinic.19 Results indicated that TCBT could suc-
cessfully reduce symptoms of OCD and was
regarded positively by service users.
The aim of the present study was to determine
whether TCBT was as effective as face-to-face
CBT for adolescents with OCD. As face-to-face
CBT for OCD is a well-established treatment,5 it
is appropriate to use it as a benchmark against
which to compare TCBT and to demonstrate non-
inferiority. It was hypothesized that:
 TCBT would not be inferior to traditional face-
to-face CBT in reducing OCD symptoms as
measured by the Children’s Yale–Brown
Obsessive-Compulsive Scale (CY-BOCS).
 TCBT would not be inferior on secondary
outcome measures of depressive symptoms,
self-report, and parent-report of adolescent
OCD symptoms, overall psychological health,
global functioning, and parental mental health
symptoms.
 The changes observed at the end of the treat-
ment period would be maintained over a 12-
month follow-up period.
METHOD
Recruitment and Inclusion Criteria
Participants were recruited by referral from primary
care general practitioners and from mental healthJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATR
VOLUME 53 NUMBER 12 DECEMBER 2014professionals within secondary and tertiary care set-
tings within the National Health Service (NHS) to a
specialist OCD clinic between 2008 and 2011. Infor-
mation about the study was conveyed by word of
mouth, letters to referring agencies, advertisements
published on Web pages of national OCD charities
within the UK, and by a research support organisation
within the NHS (the Mental Health Research Network).
The study protocol was approved by the Joint South
London and Maudsley/Institute of Psychiatry Re-
search Ethics Committee (08/H0807/12). Written
informed consent was obtained from all parents and
participants more than 16 years of age, and informed
assent from participants less than 16 years of age,
after a detailed description of the study had been
given. The trial was registered on the International
Standard Randomized Controlled Trial Number Reg-
ister (ISRCTN27070832).
Inclusion criteria were as follows: having primary
OCD according to DSM-IV criteria; having a CY-BOCS
score of 16 or greater, indicating moderate to severe
impairment; being between the ages of 11 and 18 years;
being medication-free or on a stable dose of medication
for a period of 12 weeks or more; having no suicidal
intent, drug or alcohol abuse, or psychotic symptoms;
having no learning disability or pervasive develop-
mental disability; needing and wanting CBT, and
agreeable to randomisation; and being agreeable to
parental involvement in treatment. Exclusion criteria
were the following: current diagnosis of psychosis or
current alcohol or substance abuse/dependence; En-
glish comprehension too poor to engage in treatment;
severe disabling neurological disorder; diagnosed
global learning disability or pervasive developmental
delay; and characteristics interfering with completion
of treatment within trial (e.g., a life-threatening or un-
stable medical illness).Measures
Primary Outcome Measure. The primary outcome mea-
sure was the clinician-administrated CY-BOCS,20
which was administered by a blinded rater at all time
points.
Secondary Outcome Measures. The Children’s
Obsessional Compulsive Inventory–Revised (ChOCI-
R)21 includes child- and parent-rated versions and is
aimed at capturing subjective measures of OCD
symptom severity and impairment.
The Beck Depression Inventory for Youth (BDI-Y)22
assesses symptoms of depression in adolescents. Psy-
chometric properties are sound.23
The Strengths and Difﬁculties Questionnaire
(SDQ)24 assesses child mental health symptoms more
broadly. We used the total score to provide a measure
of general psychological functioning from both a child-
rated and parent-rated perspective.
Parental mental health was assessed using the total
score of the 42-item version of the Depression, AnxietyY
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TURNER et al.and Stress Scales (DASS).25 The DASS has demon-
strated strong psychometric properties in both clinical
and community samples.26
Diagnostic Assessment, Global Functioning, and
Improvement. Blinded raters completed all diagnostic
assessments and ratings of global functioning and
improvement. Psychiatric diagnoses were established
using the Anxiety Disorders Interview Schedule for
Children (ADIS-IV-C/P).27 The Children’s Global
Impression Scale (CGAS)28 is a numeric scale ranging
from 1 (needs constant supervision: 24-hour care) to
100 (superior functioning in all areas) and was used to
rate the participant’s overall general functioning. The
Clinical Global Impression–Improvement (CGI-I) rat-
ing scale29 assessed how much the participant’s
symptoms had improved or worsened relative to
baseline. Participants were rated on a 7-point scale
ranging from 1 (very much improved) to 7 (very much
worse).
Assessment of Treatment Credibility, Expectancy, and
Satisfaction With Treatment Received. A treatment cred-
ibility and expectancy scale (modiﬁed from the mea-
sure presented by Devilly and Borkovec30 to reﬂect use
by adolescents with OCD) was used at 2 time points to
determine whether participants and their parents
viewed the treatments as equally credible. A treatment
satisfaction questionnaire was developed to assess
participant and parent satisfaction with the interven-
tion; this was given to families posttreatment. Partici-
pant and parent satisfaction was also assessed using a
qualitative methodology, which is reported separately
(Lang et al., in preparation, 2014).Procedure
Once referral to the specialist clinic was received,
young persons and parents were asked to complete the
ChOCI, SDQ, BDI (youth only), and the DASS (parents
only). A face-to-face assessment was arranged, poten-
tial participants completed the CY-BOCS, and a clinical
interview with parents was used by experienced psy-
chiatrists/clinical psychologists to establish whether
inclusion criteria were met. The study was offered, and
information was provided. Families were contacted by
telephone 1 week later, and if they were agreeable to
the study, a second clinic appointment was arranged
approximately 8 weeks after the initial meeting. At
this appointment, participants and their parents com-
pleted the ADIS-IV-C/P and the CY-BOCS in struc-
tured interviews, and self- and parent-report measures
were completed again. Families were included in the
study if participants remained symptomatic and full
inclusion criteria were met. Randomization occurred at
this time. After randomization, an appointment was
made with the treating therapist, and treatment ses-
sions commenced the following week. All treating
therapists were experienced clinical psychologists, and
all blinded raters completing assessments were either
assistant psychologists or clinical psychologists, all ofJOURN
1300 www.jaacap.orgwhom had specialist training and experience in
assessing and treating childhood OCD.
Randomization and Assessment Points
Participants were randomly allocated to CBT or TCBT
in a 1:1 ratio using a computer-generated randomiza-
tion sequence, prepared before the study commenced,
to which only the principal investigator (C.T.) had ac-
cess. No other study personnel had access to the allo-
cation; the allocation sequence was kept separate from
all trial materials and personnel. Trial enrollment
occurred at the time of the second assessment. The
integrity of the randomization table was maintained
and allocation concealment was ensured, with alloca-
tion provided only to treating therapists and allocated
participants. There were no instances of delayed or
prevented enrollment. There were no restrictions or
matching.
A repeated-measures design was used, and assess-
ments were conducted immediately before treatment
(i.e., baseline), mid-treatment (i.e., session 7), immedi-
ately after treatment (i.e., posttreatment), and at follow-
up points scheduled at 3 months, 6 months, and 12
months posttreatment. At each time point (except ses-
sion 7), participants completed the CY-BOCS, ChOCI,
SDQ, and BDI-Y, and parents completed the ChOCI,
SDQ and DASS. At session 7, all participants in both
groups were invited to the clinic for a blinded face-to-
face CY-BOCS assessment; the results of this assess-
ment were fed back to treating therapists to assist in
planning future sessions. Treatment credibility and
expectancy and a measure of therapeutic alliance were
completed by participants and parents after session 2
and session 7.
Masking Procedures
To ensure that blindness was maintained, treating
therapists and participants/parents were instructed
not to discuss the treatment that they had received with
the blinded assessors, and reminder cards were placed
in the interview rooms. After completing the assess-
ments, blinded raters noted whether blindness had
been broken (for example, if the patient had inadver-
tently revealed his/her treatment group) and, if not,
made a guess regarding the patient’s group alloca-
tion.31 A research assistant managed the allocation of
blinded assessors and monitored blindness rating
forms. Where blindness was inadvertently broken,
outcome assessors were changed.
Monitoring of Treatment Integrity
Treatment integrity was ensured in 3 ways. First, a
detailed treatment manual was used (Turner, 2006, un-
published), and, regardless of condition, participants
received a workbook with clinical information and
monitoring sheets. Second, all treating therapists received
supervision by more senior clinical psychologists who
were specialists in CBT for OCD. Finally, therapistsAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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TABLE 1 Pretreatment Clinical and Demographic Variables for Participants With Each Condition
Variable CBT (n ¼ 36) TCBT (n ¼ 36)
Age, y 14.50 (2.19) 14.19 (2.07)
Age at OCD Onset 10.97 (3.12) 11.00 (3.61)
Female Gender, % 47.2 44.4
Male Gender, % 52.8 55.6
On stable SSRI Medication, % 22.6 17.9
Previous CBT Treatment, n (%) 8 (22.2) 13 (36.1)
CY-BOCS Obsessions 11.67 (2.30) 12.36 (2.20)
CY-BOCS Compulsions 12.44 (2.05) 13.28 (2.02)
CY-BOCS Total 24.11 (4.02) 25.64 (3.86)
CHOCI-C Total 23.21 (8.70) 24.11 (7.01)
CHOCI-P Total 22.65 (8.81) 24.53 (9.12)
BDI-Y 14.44 (8.77) 14.58 (8.73)
FAS-M Total 20.33 (12.75) 21.45 (11.32)
FAS-F Total 13.36 (7.48) 13.18 (7.82)
DASS-M Total 17.68 (18.63) 15.53 (14.04)
DASS-F Total 15.33 (17.11) 8.56 (5.50)
SDQ-P Total 17.21 (3.86) 16.26 (4.37)
SDQ-C Total 16.63 (3.37) 17.13 (3.71)
CGAS 50.53 (7.06) 50.00 (7.49)
Note: Values represent mean and SD unless otherwise specified. BDI-Y ¼ Beck Depression Inventory for Youth; CBT ¼ cognitive-behavioral therapy;
CGAS ¼ Clinical Global Assessment Scale; CHOCI-C ¼ Children’s Obsessional Compulsive Inventory RevisedeChild; CHOCI-P ¼ Children’s
Obsessional Compulsive Inventory RevisedeParent; CY-BOCS ¼ Children’s YaleeBrown Obsessive Compulsive Scale; DASS-F ¼ Depression Anxiety
Stress ScaleeFather; DASS-M ¼ Depression Anxiety Stress ScaleeMother; FAS-F ¼ Family Accommodation ScaleeFather; FAS-M ¼ Family Accom-
modation ScaleeMother; OCD ¼ obsessive-compulsive disorder; SDQ-C ¼ Strengths and Difficulties QuestionnaireeChild Version; SDQ-P ¼ Strengths
and Difficulties QuestionnaireeParent Version; SSRI ¼ selective serotonin reuptake inhibitor; TCBT ¼ telephone cognitive-behavioral therapy.
TELEPHONE CBT FOR ADOLESCENT OCDwere asked to audio-record all sessions (whenever
possible) and to complete an integrity-to-protocol rating
form developed for this study. A random sample of
225 recorded sessions (25%) were then audited and
independently rated for integrity to protocol by a
doctorate-level trainee in clinical psychology. The rate
of adherence to the manual was 94% as measured by
therapist report and was 93% as measured by inde-
pendent audit. This is considered a high rate of treat-
ment ﬁdelity.32 There were no differences in adherence
ratings between conditions.
Treatment
Treatment consisted of 14 sessions of CBT delivered
by 6 experienced clinical psychologists. Treatment
was identical within conditions except that partici-
pants randomized to TCBT received all treatment
sessions via telephone. Sessions 1 and 2 consisted of
psychoeducation, sessions 3 to 12 consisted of gradual
exposure with response prevention (E/RP) and
incorporated various cognitive strategies as appro-
priate, and sessions 13 and 14 consisted of relapse
prevention and ongoing symptom management (if
required). The treatment protocol incorporated 10
minutes of parental discussion at the end of each
treatment session. Homework E/RP tasks were
assigned between sessions, and participants were
encouraged to complete daily E/RP. The treatmentJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATR
VOLUME 53 NUMBER 12 DECEMBER 2014protocol has been validated in previous trials.19,33 All
14 sessions were required to be completed within 17
weeks, allowing accommodation for illness, missed
appointments, and holidays.
Power Analysis
A noninferiority margin of 5 points on the CY-BOCS
was selected as the acceptable mean difference be-
tween conditions, based on clinical judgment and the
adult trial of TCBT conducted by Lovell et al.11 We
estimated that with a sample size of 33 in each condi-
tion, a 2-group 0.05 1-sided test would have 80% power
to reject the null hypothesis that TCBT is inferior to CBT
(i.e., the difference inmeans is 5.0 or farther from 0 in the
same direction) in favor of the alternative hypothesis
that TCBT is not inferior, assuming that the expected
difference in means is 0.0 and the common standard
deviation is 8.0. To allow for drop-outs, we sought to
recruit 72 participants (n ¼ 36 in each condition).
Statistical Analysis. Little’s Missing Completely at
Random (MCAR) test was used to establish that
missing data was missing at random. Missing values
on all outcome measures for all follow-up occasions
were imputed via Multiple Imputation using Chained
Equations (MICE) in Stata 11, with the ice command.34
Ten imputed data sets were created for the CY-BOCS,
and up to 100 imputed data sets were created for sec-
ondary outcome measures depending on the amount ofY
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FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) diagram. Note: CBT ¼ cognitive-behavioral
therapy; ITT ¼ intention to treat; TCBT ¼ telephone cognitive-behavioral therapy.
TURNER et al.missing data. The missing data at each occasion were
imputed on the basis of observed values of each mea-
sure at all other time points. Because many of the
measures were non-normally distributed, missing
values were imputed through predictive mean match-
ing,35 which replaces missing values with observed
values of similar cases. This avoids the potential for
imputed values, which fall outside the observed range
of the variable.
Data on outcome measures at each time point after
baseline were modeled using linear regression tech-
niques with treatment condition as the key covariate.
All models were also estimated separately, excluding
cases with imputed values of the outcome variable as
suggested by von Hippel.36 However, as this did not
substantively alter any of the conclusions, the results
reported here use the imputed outcome values.
Non-inferiority is established when the conﬁdence
interval for the difference between treatment condi-
tions excludes a prespeciﬁed margin of inferiority,
typically chosen to represent a clinically signiﬁcant
difference.37 As noted above, the margin of inferiorityJOURN
1302 www.jaacap.orgfor the primary outcome was set at 5 points on the CY-
BOCS scale using a 95% conﬁdence interval. TCBT
would be deemed non-inferior to CBT if the upper limit
of the 95% conﬁdence interval for the difference be-
tween TCBT and CBT is less than 5, meaning that we
are 95% conﬁdent that the “true” value of the differ-
ence is not worse than 5 points on the CY-BOCS scale.
For secondary outcome measures, the margin of infe-
riority was set for each measure at a difference of 1
standard deviation from the CBT condition mean for
each assessment point. All primary and secondary
outcomes are reported using an intent-to-treat sample
of N ¼ 72. Last available observation data were used to
determine the number of participants who could be
classiﬁed as responders (i.e., CY-BOCS reduction of
35% or more) or remitters (i.e., CY-BOCS 12).38RESULTS
Participant Characteristics
Participants were 72 adolescents aged 11 through
18 years and their parents. All participantsAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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FIGURE 2 Ninety-five percent CI for the difference in Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS)
between telephone cognitive-behavioral therapy (TCBT) and cognitive-behavioral therapy (CBT) conditions.
TELEPHONE CBT FOR ADOLESCENT OCDwere outpatients with a primary diagnosis of
OCD. Eleven young persons (15%) had a
ﬁrst-degree relative diagnosed with OCD. A total
of 21 adolescents (29%) had received a previous
trial of CBT for OCD. Comorbid diagnoses
included another anxiety disorder (n ¼ 39,
54.16%), depression or dysthymia (n ¼ 7, 9.7%),
a tic disorder or Tourette syndrome (n ¼ 6, 8.3%),
attention-deﬁcit/hyperactivity disorder (ADHD;
n ¼ 1, 1.4%), oppositional-deﬁant disorder (ODD;
n¼ 1, 1.4%), body dysmorphic disorder (BDD; n¼
1, 1.4%), and an eating disorder (n ¼ 1, 1.5%).
Table 1 presents additional demographic infor-
mation and pretreatment clinical informa-
tion; there were no signiﬁcant differences between
groups. Participants in each condition received
on average 12 of the 14 CBT sessions offered.
Attrition
Figure 1 shows the participant ﬂow throughout
the trial.
Primary Outcome
Figure 2 presents the 95% conﬁdence interval for
the CY-BOCS mean difference between CBT and
TCBT groups, and Figure 3 presents the mean
scores (with standard error) for both conditions
across time. For all assessment points through to
the 6-month follow-up, the difference between
conditions was nonsigniﬁcant, and the 95% con-
ﬁdence interval lay below the 5-point difference
margin, indicating that TCBT was not inferior to
CBT. For the 12-month follow-up point, the 95%
conﬁdence interval included the margin ofJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATR
VOLUME 53 NUMBER 12 DECEMBER 2014difference, and, based on the guidance provided
by Piaggio et al.39 for the Consolidated Standards
of Reporting Trials (CONSORT) group, we
conclude that the difference was nonsigniﬁcant;
however, non-inferiority of TCBT could not
conclusively be demonstrated at this time point.
As shown in Table 2, there were no group
differences in the proportion of the sample who
could be deﬁned as treatment responders (de-
ﬁned as participants with a 35% reduction on
the CY-BOCS) and remitters (deﬁned as partici-
pants with CY-BOCS scores 12).
Secondary Outcomes
Table S1 (available online) presents the means,
standard deviations, and 95% conﬁdence interval
data for all outcome measures. Based on the
predetermined criteria of 1 standard deviation
difference between the groups, analysis shows
that the upper bound of the conﬁdence intervals
falls within the non-inferiority margin, conﬁrm-
ing the non-inferiority hypothesis on all mea-
sures. For the CGAS, because higher scores reﬂect
a greater level of overall functioning, the lower-
bound conﬁdence interval is the critical value,
again conﬁrming non-inferiority.
Clinician-Administrated Measure of Global
Improvement and Functioning
There were no group differences in clinician-rated
global functioning using the CGAS with non-
inferiority of TCBT demonstrated, and no group
differences with regard to global improvement
using the CGI-I scale. Participants in bothY
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FIGURE 3 Total Children’s Yale–Brown Obsessive Compulsive Scale (CY-BOCS) mean scores (with standard error) for
the cognitive-behavioral therapy (CBT) and telephone cognitive-behavioral therapy (TCBT) conditions. Note: M-FU ¼
months of follow-up; post-tx ¼ posttreatment.
TURNER et al.conditions improved over the course of the study,
and improvements were maintained over the
follow-up period (Table S1, available online).
Treatment Credibility and Expectancy
Credibility ratings were provided at the end of
session 2. There were no signiﬁcant differences in
treatment credibility ratings provided by adoles-
cents in the TCBT group (mean ¼ 23.26, SD ¼
5.62) compared with those in the face-to-face
group (mean ¼ 22.12, SD ¼ 4.73); t41 ¼ 0.48,
p ¼ .31. Similarly, there were no signiﬁcant dif-
ferences in credibility ratings provided by parents
in the TCBT group (mean ¼ 23.61, SD ¼ 4.64)
compared with those in the face-to-face group
(mean ¼ 23.08, SD ¼ 5.41); t39 ¼ 0.74, p ¼ .96.
Satisfaction With Treatment Received
Adolescents reported high levels of satisfaction,
with 94.4% of youth reporting satisfaction with
the help received, and no signiﬁcant differences
between groups (TCBT ¼ 96.3%, CBT ¼ 92.6%,
c2[1, n ¼ 54] ¼ 0.35, p ¼ .552). The majority of
adolescents (59.3%) reported that they were very
happy with the treatment condition to which they
were allocated. There was a signiﬁcant difference
between groups, with 77.8% of adolescents in the
TCBT condition being very happy with their
group allocation compared to 40.7% of adoles-
cents in the CBT condition: c2(3, n ¼ 54) ¼ 8.89,
p ¼ .031. Parents similarly reported high levels
of satisfaction, with no signiﬁcant difference
between treatment groups (TCBT ¼ 93.1%,
CBT ¼ 88.9%, c2[3, n ¼ 56] ¼ 2.11, p ¼ .349).JOURN
1304 www.jaacap.orgAssessment of Blinding
Treatment condition was inadvertently revealed
to blinded assessors in a small number of cases at
each time point as follows: 2 patients at session 7; 3
patients at session 14; 1 patient at 3-month follow-
up; 2 patients at 6-month follow-up; and 4 patients
at 12-month follow-up. Excluding those, the blind
raters’ guesses regarding treatment condition
were no better than chance at session 7 (k ¼ 0.259,
p¼ .061), session 14 (k¼0.003, p¼ .984), 3-month
follow-up (k¼ 0.005, p ¼ .967), 6-month follow-up
(k ¼ 0.164, p ¼ .227), or 12-month follow-up
(k ¼ 0.064, p ¼ .654).
DISCUSSION
This study demonstrates that CBT for child and
adolescent OCD delivered by telephone is not
inferior in efﬁcacy to the traditional method of
clinic-based, face-to-face CBT. Blinded assessor
ratings of OCD symptom severity demonstrated
non-inferiority of TCBT from posttreatment
through to 6-month follow-up. The results have
signiﬁcant potential to increase the accessibility of
CBT for adolescents with OCD.
At 12-month follow-up, although the conﬁ-
dence intervals for the mean CY-BOCS score in
the TCBT group fell outside the non-inferiority
margin, no signiﬁcant difference was observed
between the conditions with respect to clinician-
rated OCD symptoms, and importantly, ac-
cording to child- and parent-reported OCD
symptoms, TCBT was non-inferior to face-to-
face CBT at all follow-up points. Similarly,
non-inferiority was established at all time pointsAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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TABLE 2 Cognitive-Behavioral Therapy (CBT) Sessions,
and Percentage of Sample Classified as CBT Respondersa
and Remitters,b Based on Last Available Observation
CBT TCBT c2 Df P
Responders, %
Posttreatment 90.6 87.5 0.160 1 .689
3-mo follow-up 92.0 89.7 0.088 1 .767
6-mo follow-up 84.0 92.0 0.758 1 .384
12-mo follow-up 94.4 88.9 0.364 1 .546
Remitters, %
Posttreatment 60.6 58.8 0.022 1 .882
3-mo follow-up 51.7 58.1 0.243 1 .622
6-mo follow-up 53.8 77.8 3.38 1 .066
12-mo follow-up 83.3 77.8 0.177 1 .674
Note: Mo ¼ month; TCBT ¼ telephone cognitive-behavioral therapy.
aCBT responders 35% Children’s YaleeBrown Obsessive
Compulsive Scale (CY-BOCS) reduction.
bRemitters 12 on CY-BOCS.
TELEPHONE CBT FOR ADOLESCENT OCDfor all other secondary outcome measures in-
cluding child depressive symptoms, child global
functioning, parental accommodation of OCD
symptoms, and parental psychopathology.
Participant and parent responses to the tele-
phone condition were positive. Adherence rates
for both conditions were high, and participants
and parents from both conditions reported high
levels of satisfaction with the treatment received.
Of note, a small number of families declined to
participate in the study, as they did not want to
be allocated to the TCBT condition (n ¼ 8).
Conversely, there was a small number of families
(n ¼ 3) who declined participation because they
did not want to be allocated to the CBT condition,
and the reason given was that the travel to the
clinic was a deterrent. Interestingly, there was a
signiﬁcant difference between groups with regard
to the number of young persons who reported
satisfaction with their allocated condition, and a
greater number of young persons reported being
satisﬁed with the TCBT condition. Participants
and parents within each condition reported
equivalent levels of alliance/engagement with
their treating therapist, and both conditions were
perceived as credible.
Given that a non-inferioritydesignwasused, it is
important to consider whether face-to-face CBT
was as effective as in previous trials. We found that
face-to-face CBT was associated with a 51% reduc-
tion inOCDsymptomseverity over the acutephase
of treatment and a 67% reduction from pretreat-
ment to 12-month follow-up, which is commensu-
ratewith ﬁndings from previous controlled trials.40
Furthermore, at posttreatment, around 90% wereJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATR
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mitters, rates that are consistent with or better than
previous studies.33,41 Face-to-face CBT in the cur-
rent study can therefore be considered to be an
appropriate benchmark.
The current ﬁndings suggest that TCBT has
promise as a mode of treatment delivery and
supports the general move toward integrating
telehealth into mental health services.42 TCBT has
the potential to extend the availability of CBT to
remote areas and/or regions with workforce
shortages, thereby reducing geographical in-
equalities in the availability of CBT.43 More
generally, TCBT may be preferred to traditional
face-to-face CBT by some families and services,
because of its convenience and its potential to
reduce demands on resources (e.g., travel, clinic
space). A previous trial conducted among adults
with OCD found that TCBT sessions were overall
50% shorter than face-to-face sessions, yet the 2
treatments were associated with equivalent clin-
ical outcomes, suggesting a possible economic
beneﬁt of TCBT.11 Further research is needed to
establish whether TCBT may be more cost-
effective than face-to-face CBT in pediatric OCD.
There are several strengths to this study, in-
cluding the following: conformity to CONSORT
guidelines for non-inferiority trials; adequate
power to test the hypotheses; the inclusion of
participants/parents who were seeking help
through the UK NHS; inclusion/exclusion cri-
teria designed to maximize generalizability; good
retention (i.e., low attrition) rates; use of blinded
outcome assessors; and use of a treatment
protocol shown to be effective.19,33 TCBT was
therefore assessed for non-inferiority against a
gold-standard treatment.
The ﬁndings should also be considered in the
context of the study’s limitations. First, the design
did not include a no-treatment or placebo
treatment control condition. Second, the non-
inferiority threshold of 5 could be considered
as high, and future studies may consider adopting
a more stringent threshold to allow for the poten-
tial detection of small between-group differences.
Third, the study was conducted by experienced
CBT therapists, and it cannot be assumed that the
ﬁndings would necessarily translate to less expe-
rienced therapists or other service settings,
although previous research has demonstrated that
manualized CBT for pediatric OCD is transport-
able and effective when delivered in community
settings by nonspecialist therapists.44 Fourth,
although every effort was made to complete anY
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through 12, theremay have been some instances in
which this was not possible (e.g., because of
participant reluctance or avoidance). In addition,
we do not know whether homework compliance
differs between CBT and TCBT. Finally, the cur-
rent study included young persons aged 11
through 18 years, and although this is comparable
to previous pediatric trials, the ﬁndings may not
generalize to a younger population.
In summary, this is the ﬁrst study to demon-
strate that TCBT is as effective as face-to-face CBT
for treatment of adolescent OCD, in both the short
and medium term, and that it is associated with
high levels of patient satisfaction. Further research
is needed to explore the longer-term outcomes of
TCBT as compared to face-to-face CBT and to
examine potential predictors of outcome. Never-
theless, these ﬁndings suggest that telephone CBT
could be a promising method for overcoming
geographical barriers in accessing CBT. &13Accepted September 25, 2014.
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TABLE S1 Means (Standard Deviations), Mean Differences, and 95% CIs for Secondary Measures of Outcome
Variable CBT Mean (SD) TCBT Mean (SD)
Coefﬁcient
Mean Diff.
95% CI
Lower Bound
95% CI
Upper Bound
CY-BOCS Obsessions
Baseline 11.67 (2.30) 12.36 (2.20)
Post-tx (T3) 6.12 (3.10) 6.24 (4.23) 0.06 1.76 1.87
3-mo FU (T4) 6.12 (3.40) 6.70 (4.40) 0.38 1.56 2.31
6-mo FU (T5) 5.46 (3.31) 6.06 (4.31) 0.52 1.34 2.37
12-mo FU (T6) 4.00 (3.84) 5.71 (4.69) 1.60 0.49 3.70
CY-BOCS Compulsions
Baseline 12.44 (2.05) 13.28 (2.02)
Post-tx (T3) 5.55 (3.19) 6.82 (4.45) 1.09 0.80 2.99
3-mo FU (T4) 6.04 (3.43) 6.64 (4.43) 0.54 1.44 2.51
6-mo FU (T5) 5.57 (3.31) 5.83 (4.89) 0.16 1.87 2.19
12-mo FU (T6) 4.39 (3.80) 5.53 (4.75) 1.41 0.79 3.60
CY-BOCS Total
Baseline 24.11 (4.02) 25.64 (3.86)
Post-tx (T3) 11.72 (6.06) 12.99 (8.56) 1.06 2.61 4.73
3-mo FU (T4) 12.23 (6.48) 13.32 (8.67) 0.74 3.06 4.53
6-mo FU (T5) 10.91 (6.07) 11.90 (9.10) 0.35 3.45 4.14
12-mo FU (T6) 8.07 (7.36) 10.94 (9.17) 2.78 1.38 6.94
CHOCI-C Total
Baseline 23.21 (8.70) 24.11 (7.01)
Post-tx (T3) 14.36 (8.21) 13.14 (10.77) 1.15 5.96 3.65
3-mo FU (T4) 13.85 (8.74) 14.09 (10.05) 0.65 5.30 3.99
6-mo FU (T5) 11.53 (9.49) 13.47 (9.84) 0.67 4.20 5.54
12-mo FU (T6) 11.95 (9.84) 13.16 (10.97) 0.23 4.90 5.36
CHOCI-P Total
Baseline 22.65 (8.81) 24.53 (9.12)
Post-tx (T3) 12.26 (9.45) 12.77 (11.87) 0.24 3.29 2.81
3-mo FU (T4) 11.61 (11.59) 12.98 (10.01) 0.73 2.65 4.12
6-mo FU (T5) 11.64 (10.83) 13.06 (9.08) 0.78 2.53 4.08
12-mo FU (T6) 10.30 (11.52) 11.93 (10.68) 1.68 1.63 4.99
BDI-Y
Baseline 14.44 (8.77) 14.58 (8.73)
Post-tx (T3) 10.98 (10.16) 11.08 (11.28) 0.11 4.77 4.99
3-mo FU (T4) 11.38 (10.85) 8.16 (6.88) 3.67 8.29 0.95
6-mo FU (T5) 10.04 (9.38) 6.55 (5.02) 3.81 7.60 0.30
12-mo FU (T6) 8.22 (6.30) 6.89 (6.95) 1.71 4.95 1.52
DASS-M Total
Baseline 17.68 (18.63) 15.53 (14.04)
Post-tx (T3) 13.55 (19.95) 14.58 (16.44) 2.19 6.86 11.24
3-mo FU (T4) 16.28 (21.10) 8.96 (9.87) 6.69 14.85 1.47
6-mo FU (T5) 13.20 (13.08) 13.55 (14.27) 0.83 6.27 7.92
12-mo FU (T6) 10.60 (14.88) 13.75 (18.53) 4.27 3.59 12.13
DASS-F Total
Baseline 15.33 (17.11) 8.56 (5.50)
Post-tx (T3) 7.25 (8.92) 13.26 (19.29) 7.85 3.66 19.35
3-mo FU (T4) 16.33 (18.50) 9.50 (12.11) 5.79 15.52 3.95
6-mo FU (T5) 14.40 (19.41) 10.25 (15.57) 1.26 10.11 7.58
12-mo FU (T6) 12.79 (11.34) 6.18 (5.78) 5.04 13.39 3.31
SDQ-P Total
Baseline 17.21 (3.86) 16.26 (4.37)
Post-tx (T3) 14.37 (3.55) 15.13 (4.24) 0.89 1.06 2.85
3-mo FU (T4) 13.89 (4.72) 14.24 (4.04) 0.52 1.76 2.8
6-mo FU (T5) 13.73 (3.39) 13.78 (3.43) 0.06 1.92 2.04
12-mo FU (T6) 13.84 (4.60) 13.29 (3.74) 0.34 2.56 1.89
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TABLE S1 Continued
Variable CBT Mean (SD) TCBT Mean (SD)
Coefﬁcient
Mean Diff.
95% CI
Lower Bound
95% CI
Upper Bound
SDQ-C Total
Baseline 16.63 (3.37) 17.13 (3.71)
Post-tx (T3) 14.64 (3.36) 14.97 (3.90) 0.29 1.56 2.13
3-mo FU (T4) 14.08 (3.20) 15.08 (3.91) 0.87 0.94 2.70
6-mo FU (T5) 13.60 (2.90) 15.01 (3.64) 1.17 0.44 2.78
12-mo FU (T6) 13.64 (3.07) 14.48 (3.59) 0.83 0.94 2.60
CGAS
Baseline 50.53 (7.06) 50.00 (7.49)
Post-tx (T3) 74.28 (14.23) 71.37 (17.61) 2.56 10.18 5.06
3-mo FU (T4) 72.10 (15.01) 70.74 (17.26) 0.31 7.38 8.00
6-mo FU (T5) 71.50 (10.30) 73.22 (16.94) 3.07 4.02 9.16
12-mo FU (T6) 76.92 (15.02) 74.25 (14.06) 2.17 9.59 5.25
CGI-I
Baseline 4.12 (0.59) 4.10 (0.33) 0.02 0.25 0.21
Post-tx (T3) 1.84 (0.67) 1.98 (1.09) 0.13 0.31 0.58
3-mo FU (T4) 2.14 (1.01) 1.91 (0.92) 0.24 0.75 0.26
6-mo FU (T5) 1.97 (0.91) 1.87 (1.09) 0.11 0.64 0.42
12-mo FU (T6) 1.61 (1.09) 1.81 (1.01) 0.20 0.45 0.84
Note: BDI-Y ¼ Beck Depression Inventory for Youth; CBT ¼ cognitive-behavioral therapy; CGAS ¼ Clinical Global Assessment Scale; CGI-I ¼ Clinical
Global Impression Improvement Scale; CHOCI-C ¼ Children’s Obsessional Compulsive Inventory RevisedeChild; CHOCI-P ¼ Children’s Obsessional
Compulsive Inventory RevisedeParent; CY-BOCS ¼ Children’s YaleeBrown Obsessive Compulsive Scale; DASS-F ¼ Depression Anxiety Stress
ScaleeFather; DASS-M ¼ Depression Anxiety Stress ScaleeMother; FAS-F ¼ Family Accommodation ScaleeFather; FAS-M ¼ Family Accommo-
dation ScaleeMother; FU ¼ follow-up assessment; Post-tx ¼ posttreatment; SDQ-C ¼ Strengths and Difficulties QuestionnaireeChild Version;
SDQ-P ¼ Strengths and Difficulties QuestionnaireeParent Version; TCBT ¼ telephone cognitive-behavioral therapy.
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